Midwest Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$270K Buy
1,074
+2
+0.2% +$430 0.09% 120
2026
Q1
$233K Buy
1,072
+2
+0.2% +$444 0.1% 114
2025
Q4
$245K Buy
1,070
+1
+0.1% +$228 0.11% 109
2025
Q3
$247K Buy
+1,069
New +$218K 0.12% 104
2025
Q2
Sell
-1,065
Closed -$223K 115
2025
Q1
$223K Buy
+1,065
New +$207K 0.13% 100
2024
Q4
Sell
-1,069
Closed -$211K 112
2024
Q3
$211K Buy
+1,069
New +$200K 0.12% 103
2024
Q1
Sell
-6,258
Closed -$970K 105
2023
Q4
$970K Sell
6,258
-1,122
-15% -$164K 0.72% 37
2023
Q3
$1.1M Buy
7,380
+23
+0.3% +$3.38K 0.93% 27
2023
Q2
$991K Sell
7,357
-50
-0.7% -$7.33K 0.84% 29
2023
Q1
$1.18M Buy
+7,407
New +$1.13M 1.09% 23

Other funds holding ABBV

Midwest Financial Group's ABBV Position: Q2 2026 in Review

Midwest Financial Group increased its AbbVie (ABBV) stake by 0.19% in Q2 2026, buying an estimated $430 and bringing the position to 1,074 shares worth $270K. The position accounts for 0.09% of the portfolio, ranked #120.

Midwest Financial Group first reported a position in ABBV in Q1 2023 and has held it in 10 quarters since. The position peaked at $1.18M in Q1 2023. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Midwest Financial Group held 1,074 shares of AbbVie worth $270K as of Q2 2026.
  • Midwest Financial Group bought 2 AbbVie shares in Q2 2026, an estimated $430.
  • AbbVie made up 0.09% of Midwest Financial Group's portfolio in Q2 2026, its #120 holding.
  • Midwest Financial Group first reported a position in AbbVie in Q1 2023 and has held it in 10 quarters since.
  • Midwest Financial Group's AbbVie position peaked at $1.18M in Q1 2023.
  • 4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Midwest Financial Group's 13F filing for Q2 2026, filed 21 Jul 2026.